SIM
ABBV icon

Stratos Investment Management’s AbbVie ABBV Stock Holding History

Stratos Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.04M Buy
35,937
+4,833
+16% +$1.04M 0.33% 70
2026
Q1 		$6.76M Buy
31,104
+3,252
+12% +$721K 0.27% 80
2025
Q4 		$6.36M Buy
27,852
+699
+3% +$159K 0.26% 82
2025
Q3 		$6.29M Buy
27,153
+243
+0.9% +$49.5K 0.26% 81
2025
Q2 		$5M Buy
26,910
+1,465
+6% +$272K 0.23% 85
2025
Q1 		$5.33M Buy
25,445
+12,934
+103% +$2.51M 0.28% 76
2024
Q4 		$2.22M Buy
12,511
+439
+4% +$80.7K 0.13% 97
2024
Q3 		$2.38M Buy
12,072
+35
+0.3% +$6.53K 0.17% 94
2024
Q2 		$2.06M Buy
12,037
+1,038
+9% +$172K 0.17% 99
2024
Q1 		$2M Sell
10,999
-2,285
-17% -$394K 0.2% 91
2023
Q4 		$2.06M Sell
13,284
-261
-2% -$38.1K 0.24% 84
2023
Q3 		$2.02M Buy
13,545
+966
+8% +$142K 0.3% 73
2023
Q2 		$1.69M Buy
12,579
+1,019
+9% +$149K 0.26% 78
2023
Q1 		$1.84M Sell
11,560
-66
-0.6% -$10.1K 0.31% 69
2022
Q4 		$1.88M Sell
11,626
-141
-1% -$21.6K 0.34% 71
2022
Q3 		$1.58M Sell
11,767
-1,298
-10% -$186K 0.32% 73
2022
Q2 		$2M Sell
13,065
-92
-0.7% -$14.1K 0.38% 66
2022
Q1 		$2.13M Buy
13,157
+556
+4% +$80.8K 0.35% 68
2021
Q4 		$1.71M Buy
12,601
+1,653
+15% +$195K 0.27% 81
2021
Q3 		$1.18M Buy
10,948
+2,491
+29% +$285K 0.21% 94
2021
Q2 		$953K Buy
8,457
+1,064
+14% +$120K 0.26% 74
2021
Q1 		$800K Sell
7,393
-2,492
-25% -$267K 0.25% 76
2020
Q4 		$1.06M Buy
9,885
+1,287
+15% +$124K 0.33% 73
2020
Q3 		$753K Buy
8,598
+2,103
+32% +$198K 0.27% 76
2020
Q2 		$638K Buy
6,495
+2,010
+45% +$177K 0.27% 76
2020
Q1 		$342K Buy
+4,485
New +$382K 0.18% 81

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stratos Investment Management's ABBV Position: Q2 2026 in Review

Stratos Investment Management increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $1.04M and bringing the position to 35,937 shares worth $9.04M. The position accounts for 0.33% of the portfolio, ranked #70.

Stratos Investment Management first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stratos Investment Management held 35,937 shares of AbbVie worth $9.04M as of Q2 2026.
  • Stratos Investment Management bought 4,833 AbbVie shares in Q2 2026, an estimated $1.04M.
  • AbbVie made up 0.33% of Stratos Investment Management's portfolio in Q2 2026, its #70 holding.
  • Stratos Investment Management first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stratos Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.